Latham & Watkins has advised Citi, Barclays, and Jefferies as global coordinators and placing agents on the deal. Bank Leumi announced its NIS2.75 billion capital raising as...
Leumi’s NIS2.75 Billion Capital Raising
Cogent Biosciences’ $150 Million Upsized Shares Offering and Pre-funded Warrants
Latham & Watkins represented the underwriters in the offering. Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases,...
Hayward Holdings’ $348 Million Secondary Offering
Ropes & Gray advised Hayward, while Davis Polk advised the several underwriters in the offering. Hayward Holdings, Inc. executed a $348 million follow-on public offering of its...
Deciphera Pharmaceuticals’ $172.5 Million Stock and Pre-Funded Warrants Offering
Davis Polk advised the joint book-running managers, J.P. Morgan Securities LLC and Jefferie, in the offering. Deciphera Pharmaceuticals, Inc. executed a $172.5 million SEC-registered common stock and...
Hillman Solutions Corp.’s $130 Million Common Stock Offering
Latham & Watkins represented the underwriters in the offering. Hillman Solutions Corp., a leading provider of hardware products and merchandising solutions, has announced the upsize and...
Xponential Fitness’ Common Stock Offering
Davis Polk advised Xponential Fitness, while Latham & Watkins represented the underwriters in the offering. Xponential Fitness, Inc., the largest global franchisor of boutique fitness brands,...
Travere Therapeutics’ $275 Million Convertible Senior Notes Offering
Latham & Watkins represented the underwriters in the offering. Travere Therapeutics, Inc. executed its offering of US$275 million aggregate principal amount of 2.25% convertible senior notes due...
Peabody’s $275 Million Convertible Senior Notes Offering
Latham & Watkins represented the initial purchasers in the offering. Peabody, a leading coal producer, has announced the pricing of its offering of US$275,000,000 aggregate principal amount...
NETSTREIT’s Common Stock Offering
Vinson & Elkins advised the underwriters on the deal. NETSTREIT Corp. announced its public offering of 9,000,000 shares of its common stock at a price to the...
Vaxcyte’s $100 Million Shares Offering
Latham & Watkins represented the underwriters in the transaction. Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of...
ProKidney’s Combination With Social Capital Suvretta Holdings Corp. III
Wachtell, Lipton, Rosen & Katz acted as legal advisor to SCS. Davis Polk & Wardwell and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C, Matheson, Akin...
CinCor Pharma’s $193.6 Million IPO
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its...